News | Breast Imaging | August 17, 2016

Cianna Medical Receives Additional FDA Clearance for Savi Scout Radar Localization System

Extended flexibility for reflector placement supports improved patient and hospital scheduling

Cianna Medical, Savi Scout radar localization system, breast lesions, additional FDA clearance

August 17, 2016 — Cianna Medical Inc. announced the company has received an additional U.S. Food and Drug Administration (FDA) 510(k) clearance for the Savi Scout radar localization system, allowing the reflector to be placed at the lumpectomy site up to 30 days prior to surgical removal. Scout, the first medical device to use radar in human tissue, is a tool for localizing and directing the removal of non-palpable breast lesions.  

“The new clearance enabling reflector placement up to 30 days before surgery provides us even more flexibility with scheduling,” said Charles Cox, M.D. “As an early adopter and ongoing user of Scout, I’ve found the technology to be highly intuitive, easy to implement and a significant improvement over wire localization in terms of patient experience. Importantly, use of Scout also supports greater efficiency in the hospital with less wait time for both patients and physicians.”

Peer-reviewed data recently published in the July issue of Annals of Surgical Oncology demonstrated 100 percent surgical success, with significantly lower repeat surgery rates than those reported when using wire localization. In all cases where localization was performed, targeted lesions and reflectors were successfully removed without any observed reflector migration. In another key study finding, researchers concluded that the Scout reflector could be reliably detected up to 5 cm from the handpiece.

The study also demonstrated high clinician and patient satisfaction with Scout. Overall, physicians reported favorably on patient comfort, patient anxiety and overall patient experience, and a majority of physicians (85 percent) reported workflow improvement with the device compared with wire localization. On a scale of 1-5, where 3 was equal to wire localization, surgeons favorably rated ability to start cases earlier at 4.9, 4.4 for patient wait times and 4.4 for reduction in operating room (OR) scheduling delays. Radiologists and surgeons also reported a 4.1 for a better overall patient experience. Post-procedure survey data indicated that 97 percent of patients would recommend Scout to others.

The study also received the 2016 Scientific Impact Award at the Society of Breast Surgeons (ASBrS) Annual Meeting, recognition given annually to the clinical research presentation that is considered to have the greatest scientific impact on breast cancer care, as judged by surgeon attendees.

The Scout system features a reflector that is placed at the tumor site up to 30 days before a lumpectomy or surgical biopsy. During the procedure, the surgeon scans the breast using the Scout handpiece, which emits infrared light and a micro-impulse radar signal to detect the location of the reflector. Real-time audible and visual indicators assist the surgeon in accurately locating the reflector, along with the target tissue. This higher level of localization precision allows better surgical planning that may improve cosmetic results.

For more information: www.ciannamedical.com

Related Content

Novel Technique May Significantly Reduce Breast Biopsies
News | Breast Biopsy Systems | January 17, 2019
A novel technique that uses mammography to determine the biological tissue composition of a tumor could help reduce...
Digital Mammography Increases Breast Cancer Detection
News | Mammography | January 16, 2019
The shift from film to digital mammography increased the detection of breast cancer by 14 percent overall in the United...
Artificial Intelligence Used in Clinical Practice to Measure Breast Density
News | Artificial Intelligence | January 15, 2019
An artificial intelligence (AI) algorithm measures breast density at the level of an experienced mammographer,...
Sponsored Content | Videos | Breast Imaging | January 11, 2019
Supplemental screening with ABUS helps personalize breast care for women with dense breasts and offers advanced...
Electronic Brachytherapy Effective in Long-Term Study of 1,000 Early-Stage Breast Cancers
News | Brachytherapy Systems, Women's Healthcare | January 07, 2019
Breast cancer recurrence rates of patients treated with intraoperative radiation therapy (IORT) using the Xoft Axxent...
Breast Cancer Patients Have Less Heart Damage With Heart Drug and Trastuzumab
News | Cardio-oncology | January 03, 2019
Breast cancer patients who take a heart drug at the same time as trastuzumab have less heart damage, according to a...
Opto-Acoustic Imaging Helps Differentiate Breast Cancer Molecular Subtypes
News | Ultrasound Women's Health | December 20, 2018
Seno Medical Instruments Inc. (Seno Medical) reported results of a study demonstrating that morphologic and functional...
Densitas Enters Platform Partnership With Blackford
News | Breast Density | December 19, 2018
Breast imaging analytics company Densitas Inc. announced the signing of a new Alliance Partner Agreement with Blackford...
Axillary Radiotherapy and Lymph Node Surgery Yield Comparable Outcomes for Breast Cancer
News | Radiation Therapy | December 18, 2018
Early-stage breast cancer patients with cancer detected in a sentinel lymph node biopsy had comparable 10-year...
RSNA Study Shows Real-Time Indicator Improves Mammographic Compression
News | Mammography | December 12, 2018
Sigmascreening recently announced that more than 100,000 women have had mammography exams with the Sensitive Sigma...